Navigation Links
Sysmex America Names Industry Veteran to Business Development Post
Date:7/10/2009

MUNDELEIN, Ill., July 10 /PRNewswire/ -- Sysmex America, Inc., a leading medical diagnostic instrument manufacturer and information systems developer, today announced the appointment of Jim Cusack as Director of Business Development and Strategic Alliances, said Ralph Taylor, Vice President of Marketing & Medical Affairs, Sysmex America. Cusack will serve a key role in managing the company's existing business partnerships and in identifying new alliances that strategically complement Sysmex's portfolio development and enhance the company's U.S. products and services offering, added Taylor. Cusack will report directly to the leadership of Marketing & Medical Affairs.

"Jim's solid business development competencies in finance, operations, P & L and negotiations provide a wealth of knowledge from which our company can draw as Sysmex America fortifies its strategic alliance and portfolio development initiatives. We trust his comprehensive financial and operations background in life sciences and diagnostics will serve us well. We look forward to his leadership in this area," said Taylor.

Prior to joining Sysmex America, Cusack primarily served in a business development capacity for Leica Microsystems, Inc., a Division of the Danaher Corporation; USC Consulting Group LLC; and Abbott Laboratories. In each of these companies, his responsibilities included the assessment, cultivation and negotiation of a variety of partnerships and collaborations with pharmaceutical and biotech companies as well as commercial reference laboratories. Cusack's finance and healthcare industry experience was gained through his associations with Bay City Capital, LLC and Dain Rauscher Wessels, where he directed venture capital funding analysis and equity research respectively.

Cusack earned his Masters of Business Administration with a concentration in Finance from the University Of Chicago Graduate School Of Business. His affiliation with the university also included his work in the development, licensing and commercialization of new technologies derived from university-based research via the Arch Development Corporation, Chicago. Cusack received his Bachelor's degree in Economics from Dickinson College, Carlisle, Pennsylvania.

About Sysmex America, Inc.

Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a world leader in clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems. Serving customers for over 40 years, Sysmex focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide. For more information about Sysmex, please visit www.sysmex.com/usa.


'/>"/>
SOURCE Sysmex America, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Sysmex America Awarded Hematology Contract by Amerinet
2. Sysmex America Receives FDA Clearance for XE-5000(TM) Hematology Analyzer
3. Sysmex America to Enable Prolonged Hematology Instrument Uptime for Hagerstown Medical Laboratory With 1,000th SNCS Activation
4. Sysmex Announces Brand Change
5. Sysmex America to Release e-Verify(TM), Powered By SNCS(TM)
6. Sysmex Customer Satisfaction Ranks Highest in Independent Market Research
7. Sysmex America Introduces On Demand Middleware Training Tool
8. Sysmex Corporation Announces Organizational Changes
9. Siemens and Sysmex Renew Global Agreement
10. BioReference Laboratories Partners With Sysmex America
11. DaVita Study Demonstrates Clinical Application of Sysmex Reticulocyte Hemoglobin Equivalent (RET-He) Parameter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium determination is consistently becoming ... require expert user knowledge. In a live webinar on April 11th and October ... highly accurate, determination of sodium. , It has long been known that too ...
(Date:3/27/2017)... CA (PRWEB) , ... March 27, 2017 , ... ... has entered a settlement agreement to resolve the pending litigation between itself and ... for the District of Utah). , “I am thrilled to announce that we ...
(Date:3/27/2017)... RICHEY, Fla. (PRWEB) , ... March 27, 2017 ... ... drug overdose deaths soared 167%,(1) with opioids alone responsible for over 33,000 of ... Kevin McCarty has sponsored Assembly Bill (AB) 1512, which proposes a tax on ...
(Date:3/27/2017)... ... , ... Harris Communications, Inc., a leading provider of assistive technology for ... Deaf Seniors of America Conference, April 4-7 at the Hotel Westin Galleria in Houston. ... staff from Harris Communications and to try out the newest assistive devices available to ...
(Date:3/25/2017)... ... March 25, 2017 , ... Getting earned media coverage meaningful for Garden Media ... All through the year, Garden Media aims to provide material helpful to clients’ goals ... pitching client’s key messages to gain coveted media placements, Garden Media wows ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Therapix Biosciences Ltd. (NASDAQ: ... the development of cannabinoid-based drugs, today announced the ... the United States of 2,000,000 American ... shares of the Company, at a price of ... the underwriters a 45-day over-allotment option to purchase ...
(Date:3/27/2017)... March 27, 2017  A recent study at Shriners ... freestanding hospitals in the country dedicated to the treatment ... surgery, concluded that the Surfacide Helios ® UV-C ... in reducing bacterial pathogens not killed by the EVS ... at the American Burn Association,s 49th Annual Meeting in ...
(Date:3/27/2017)... March 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an ... passed early toxicology and efficacy studies. The company is ... a specific protein, MAGE A, in an effort to ... After 4 weeks of treatment in ... very little toxicity in a full toxicology report of ...
Breaking Medicine Technology: